{{Rsnum
|rsid=2886161
|Gene=NFE2L2
|Chromosome=2
|position=177263111
|Orientation=plus
|GMAF=0.3512
|Gene_s=NFE2L2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 6.2 | 47.7 | 46.2
| HCB | 24.4 | 40.0 | 35.6
| JPT | 27.3 | 45.5 | 27.3
| YRI | 3.2 | 33.3 | 63.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 24.4 | 40.0 | 35.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24528044
|Title=Association of NRF2 Polymorphism with Cholangiocarcinoma Prognosis in Thai Patients
}}

{{PMID Auto
|PMID=20196834
|Title=Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}